Dashboard PDUFA PDUFA History Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free public preview Track CERENO with free AI briefings, catalyst countdowns, and dilution alerts.

CERENO

FDA catalysts, PDUFA dates with approval probability, drug pipeline, cash runway and insider activity — updated automatically from SEC, FDA and ClinicalTrials.gov data.

🧪 Upcoming Trial Catalysts

2025-12-04 · N/A — Results Expected — The Effects of Drug Candidate CS1 on Lung Structure and Function Utilizing FRI
2024-08-01 · Phase 2 — Results Expected — Effect of CS1 in Subjects With Pulmonary Arterial Hypertension
2018-02-28 · Phase 1 — Results Expected — Study Investigation Pharmacokinetics and Pharmacodynamics of CS1

📊 Drug Pipeline

Drug	Indication	Phase	Status
CS1 Administration	Pulmonary Arterial Hypertension	PHASE2	COMPLETED
CS1-Sodium Valproate	Thrombosis	PHASE1	COMPLETED
CS1	Pulmonary Arterial Hypertension	N/A	AVAILABLE

Get the full CERENO picture

A free BioRadar account adds AI daily briefings, sentiment tracking, trial enrollment progress, and email alerts for CERENO and 2 more tickers of your choice.

Create Free Account →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z